XO Health Powers Provider Search and Improved Transparency with Kyruus Health BOSTON, MA – JULY 16, 2024 – XO Health, an innovative health care services organization designed by and for self-insured employers, has announced a strategic partnership with Kyruus...
Cogent Biosciences Announces Positive FDA Meeting and Alignment on MS2D2, a Novel Patient Reported Outcome Measure for the SUMMIT Trial Enrollment in SUMMIT Part 2 remains on track for completion in Q2 2025 with top-line results expected by end of 2025 WALTHAM, Mass....
COGENT BIOSCIENCES ANNOUNCES ADDITIONAL CLINICAL DATA FROM PART 1 OF ITS ONGOING SUMMIT TRIAL EVALUATING BEZUCLASTINIB IN PATIENTS WITH NONADVANCED SYSTEMIC MASTOCYTOSIS (NONADVSM) Patients treated with 100 mg bezuclastinib showed substantial reduction in their most...
Truveris Secures $15 Million in Series E Funding ThroughCanaan Partners and New Leaf Venture Partners New funding by existing investors will support company’s next stage of development and core business growth. Truveris, the leader in pharmacy cost containment and...
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) – After six months of additional follow-up, clinical benefit rate (63%), overall response rate (41.9%), median progression-free survival...
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion Deciphera Shareholders to Receive $25.60 per Share in Cash Deciphera’s Kinase Inhibitor Expertise and Established Commercialization Platform in Key Markets Will Reinforce ONO...
Recent Comments